“At the moment, we do not have enough information about how this strain affects the effectiveness of approved vaccines.
But we are working to obtain this information.
In any case, we are ready for quick measures, "- quotes RIA Novosti statement of the representative of the regulator Marco Cavaleri.
He also called on vaccine companies to share laboratory tests with the regulator on the level of neutralization of the omicron.
Earlier, the director of the Vector Scientific Center Rinat Maksyutov said that data on the effectiveness of the EpiVacCorona vaccine against the Omicron COVID-19 strain may appear in mid-January.